Recordati(0KBS)
EUR --+0.00%
Reward56Moderate
Risk14Low
📊50%Data
Strong 17% profit margin · 3.1% dividend yield · Revenue growing 11% YoY
0KBS
+0.0 · +0.00%
EUR · LSE
Recordati |
Defensive Anchor
Market Cap:9.81Bn
ℹ️
Reward Rating
56
Moderate
Bottom 50% (model universe)
50% data coverage
ℹ️
Risk Rating
14
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0KBS to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Recordati?

Recordati Industria Chimica e Farmaceutica S.

0KBS · Verdict

Solid reward · low risk

0KBS scores well on cash flow and balance sheet with no major weaknesses flagged in the model.

Based on 75% data coverage

0KBS · Verdict

What’s working & what to watch

Strengths 3

  • Cash flow95/100

    Top decile vs peers

  • Balance sheet89/100

    Top decile vs peers

  • Volatility80/100

    Top decile vs peers

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is Recordati?

Recordati Industria Chimica e Farmaceutica S. , together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. The company is listed on the LSE in UK, with a market capitalisation of 9.81B.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (56)

The scoring profile indicates moderate reward potential, with valuation and growth as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market Cap9.81B
P/E RatioN/A
Dividend Yield3.08%
52 Week High54.6131
52 Week Low43.78
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares OutstandingN/A
No. of Employees4,614
IndustryN/A
ExchangeLSE
Beta0.529
CurrencyEUR